Published in

Lippincott, Williams & Wilkins, Current Opinion in Allergy and Clinical Immunology, 5(9), p. 454-465, 2009

DOI: 10.1097/aci.0b013e3283303ebb

Links

Tools

Export citation

Search in Google Scholar

Multiple action agents and the eye: do they really stabilize mast cells?:

Journal article published in 2009 by Alessandro Lambiase ORCID, Alessandra Micera, Stefano Bonini ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Multiple action drugs, such as azelastine, epinastine, ketotifen and olopatadine, have recently been suggested to combine antihistaminic effect, mast cell stabilization and anti-inflammatory action. This pharmaceutical class is, therefore, rapidly becoming the first choice for prevention and treatment for allergic conjunctivitis.